These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2552161)

  • 1. Polyomavirus genome and polyomavirus enhancer-driven gene expression during myogenesis.
    Maione R; Felsani A; Pozzi L; Caruso M; Amati P
    J Virol; 1989 Nov; 63(11):4890-7. PubMed ID: 2552161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of in vitro myogenic differentiation by a polyomavirus early function.
    Maione R; Fimia GM; Amati P
    Oncogene; 1992 Jan; 7(1):85-93. PubMed ID: 1311065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of polyomavirus late promoter activity by viral early proteins.
    Kern FG; Pellegrini S; Cowie A; Basilico C
    J Virol; 1986 Oct; 60(1):275-85. PubMed ID: 3018290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agent doxorubicin inhibits myogenic differentiation of C2 myoblasts.
    Kurabayashi M; Jeyaseelan R; Kedes L
    J Biol Chem; 1993 Mar; 268(8):5524-9. PubMed ID: 8449915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E1A represses wild-type and F9-selected polyomavirus DNA replication by a mechanism not requiring depression of large tumor antigen transcription.
    DePolo NJ; Villarreal LP
    J Virol; 1991 Jun; 65(6):2921-8. PubMed ID: 1851864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of viral and cellular promoter activity by polyomavirus early proteins.
    Pannuti A; La Mantia G; Lania L
    Nucleic Acids Res; 1987 Feb; 15(4):1595-613. PubMed ID: 3029721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yeast GAL4 protein transactivates the polyomavirus origin of DNA replication in mouse cells.
    Baru M; Shlissel M; Manor H
    J Virol; 1991 Jul; 65(7):3496-503. PubMed ID: 1645781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of the individual enhancer core sequences of polyomavirus: cell-specific uncoupling of DNA replication from transcription.
    Campbell BA; Villarreal LP
    Mol Cell Biol; 1988 May; 8(5):1993-2004. PubMed ID: 2838739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control elements situated downstream of the major transcriptional start site are sufficient for highly efficient polyomavirus late transcription.
    Bourachot B; Yaniv M; Herbomel P
    J Virol; 1989 Jun; 63(6):2567-77. PubMed ID: 2542572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene.
    Olive DM; al-Mulla W; Simsek M; Zarban S; al-Nakib W
    Arch Virol; 1990; 112(1-2):67-80. PubMed ID: 2142416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferin, a prolactin/growth hormone-like peptide represses myogenic-specific transcription by the suppression of an essential serum response factor-like DNA-binding activity.
    Muscat GE; Gobius K; Emery J
    Mol Endocrinol; 1991 Jun; 5(6):802-14. PubMed ID: 1656242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the mouse L32 ribosomal protein promoter elements in mouse myoblasts, fibers, and L cells.
    Harris SA; Dudov KP; Bowman LH
    J Cell Biochem; 1992 Oct; 50(2):178-89. PubMed ID: 1429883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice.
    Rochford R; Campbell BA; Villarreal LP
    J Virol; 1990 Feb; 64(2):476-85. PubMed ID: 2153218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion analysis of the polyomavirus late promoter: evidence for both positive and negative elements in the absence of early proteins.
    Cahill KB; Carmichael GG
    J Virol; 1989 Sep; 63(9):3634-42. PubMed ID: 2547989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of cellular differentiation determines the activity of the adenovirus E1A enhancer element: evidence for negative regulation of enhancer function.
    Herbst RS; Pelletier M; Boczko EM; Babiss LE
    J Virol; 1990 Jan; 64(1):161-72. PubMed ID: 2136708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.
    Edmondson DG; Olson EN
    Genes Dev; 1989 May; 3(5):628-40. PubMed ID: 2473006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis.
    Lafyatis R; Lechleider R; Roberts AB; Sporn MB
    Mol Cell Biol; 1991 Jul; 11(7):3795-803. PubMed ID: 1710772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of polyomavirus DNA replication by carcinogens in polyomavirus-transformed rat cells: evidence that the viral enhancer is not the primary target in the induction pathway.
    Baru M; Shlissel M; Manor H
    J Virol; 1992 Feb; 66(2):1261-6. PubMed ID: 1309902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
    Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
    Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level desmin expression depends on a muscle-specific enhancer.
    Li ZL; Paulin D
    J Biol Chem; 1991 Apr; 266(10):6562-70. PubMed ID: 2007603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.